Skip to main content

$0.265 0.005 (1.92%)

High

$0.27

Low

$0.26

Trades

10

Turnover

$30,696

Volume

117,402
30 June 2023 at 3:52pm
Register to track EYE and receive email alerts.

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.

Expand Company Description

Market Cap (10-Oct)

$42,376,284 (1,224th)

Close (30-Jun)

$0.265

Volume (30-Jun)

117,402

Shortsold (20-Jul)

12,636 (0.01%) (485th)

52w High

$0.325

52w Low

$0.115

P/E

-

EPS

-0.04
Subject
EYE Ann: Investment Presentation

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change in substantial holding

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Cleansing Notice

EYE Ann: iTrack Advance First Surgeries and Sales in USA

EYE Ann: Results of General Meeting

EYE Ann: FDA Clears iTrack Advance for US Launch

EYE Ann: Notice Of General Meeting

EYE Ann: Cleansing notice

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Proposed issue of securities - EYE

EYE Ann: Reinstatement to Quotation

EYE Ann: Investor Presentation

EYE Ann: Nova Eye Completes Placement

EYE Ann: Suspension from Official Quotation

EYE Ann: Half Year Accounts

EYE Ann: Trading Halt

EYE Ann: Glaucoma Surgical Devices Sales Update

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Additional Clinical Application for 2RT

EYE Ann: Status of MArket Clearance for iTrack Advance in the USA

EYE Ann: Application for quotation of securities - EYE

EYE Ann: AGM Voting Results

EYE Ann: AGM presentation 2022

EYE Ann: Clarification Glaucoma Surgical Devices Sales Update

EYE Ann: Glaucoma Surgical Devices Sales Update

EYE Ann: AlphRet Completes Initial Recruitment of Investigator Sites

EYE Ann: Notice of Annual General Meeting 2022

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: 2RT Presentation Professor Robyn H Guymer

EYE Ann: Appendix 3Y T Spurling

EYE Ann: AGM Date and Directors Nominations

EYE Ann: 2RT Webinar Professor Robyn H Guymer MMBBS, PHD

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Appendix 4G and Corporate Governance Statement

EYE Ann: Investor Presentation FY22

EYE Ann: Results Announcement FY22

EYE Ann: Appendix 4E and Annual Report FY22

EYE Ann: Expiry of Voluntary Escrow Conditions

EYE Ann: Glaucoma Sales update

EYE Ann: iTrack Advance Commercial Roll-Out Commenced

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: Application for quotation of securities - EYE

Register to track EYE and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM